ArriVent BioPharma (AVBP) News Today $20.76 -0.35 (-1.64%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$20.76 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVBP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period ArriVent BioPharma expects to raise $75M from stock saleJuly 2 at 6:45 PM | bizjournals.comArriVent BioPharma (NASDAQ:AVBP) Sees Large Volume Increase - Time to Buy?July 2 at 12:19 PM | marketbeat.comArriVent BioPharma prices $75M equity offeringJuly 2 at 8:42 AM | msn.comArriVent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded WarrantsJuly 1, 2025 | globenewswire.comArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded WarrantsJuly 1, 2025 | globenewswire.comArriVent BioPharma (NASDAQ:AVBP) Trading Down 4.5% - Should You Sell?June 30, 2025 | marketbeat.comLifesci Capital Has Negative Outlook of AVBP FY2025 EarningsJune 28, 2025 | americanbankingnews.comArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives Consensus Recommendation of "Buy" from BrokeragesJune 28, 2025 | americanbankingnews.comArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Rating of "Buy" by BrokeragesJune 28, 2025 | marketbeat.comAnalysts Issue Forecasts for AVBP Q2 EarningsJune 27, 2025 | americanbankingnews.comClear Street Initiates Coverage of ArriVent BioPharma (AVBP) with Buy RecommendationJune 26, 2025 | msn.comWhat is Lifesci Capital's Estimate for AVBP FY2025 Earnings?June 26, 2025 | marketbeat.comArriVent BioPharma (NASDAQ:AVBP) Stock Price Expected to Rise, Oppenheimer Analyst SaysJune 26, 2025 | americanbankingnews.comAVBP - ArriVent BioPharma Inc Sustainability - MorningstarJune 25, 2025 | morningstar.comMArriVent BioPharma Reports Promising Results from Phase 1b Trial for Firmonertinib in NSCLCJune 25, 2025 | msn.comQ2 Earnings Forecast for AVBP Issued By Lifesci CapitalJune 25, 2025 | marketbeat.comSG Americas Securities LLC Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP)June 25, 2025 | marketbeat.comArriVent BioPharma's (AVBP) Buy Rating Reaffirmed at GuggenheimJune 25, 2025 | americanbankingnews.comArriVent BioPharma (NASDAQ:AVBP) Shares Gap Up on Analyst UpgradeJune 24, 2025 | marketbeat.comArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $44.00 at OppenheimerJune 24, 2025 | marketbeat.comArriVent BioPharma's (AVBP) "Buy" Rating Reaffirmed at GuggenheimJune 24, 2025 | marketbeat.comArriVent BioPharma Reports Positive Phase 1b Study ResultsJune 23, 2025 | tipranks.comArriVent BioPharma (NASDAQ:AVBP) Sees Large Volume Increase - Here's WhyJune 23, 2025 | marketbeat.comArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal StudyJune 23, 2025 | globenewswire.comArriVent BioPharma to Host Investor Event on Groundbreaking Firmonertinib Program for EGFR Mutant NSCLCJune 21, 2025 | msn.comArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLCJune 20, 2025 | globenewswire.comArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by California State Teachers Retirement SystemJune 12, 2025 | marketbeat.comOptimistic Outlook for ArriVent BioPharma, Inc. Amid Promising Developments and Market SupportJune 9, 2025 | tipranks.comWellington Management Group LLP Takes $1.12 Million Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP)June 7, 2025 | marketbeat.comArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Still a Buy?June 4, 2025 | marketbeat.comMillennium Management LLC Reduces Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP)June 4, 2025 | marketbeat.comArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of "Buy" by AnalystsJune 3, 2025 | marketbeat.comBNP Paribas Financial Markets Decreases Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP)June 2, 2025 | marketbeat.comArriVent BioPharma (NASDAQ:AVBP) Shares Up 6.7% - Here's WhyMay 30, 2025 | marketbeat.comInfinitum Asset Management LLC Buys Shares of 1,643,923 ArriVent BioPharma, Inc. (NASDAQ:AVBP)May 28, 2025 | marketbeat.comWoodline Partners LP Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP)May 27, 2025 | marketbeat.comArriVent BioPharma (NASDAQ:AVBP) Trading Down 4.5% - Time to Sell?May 25, 2025 | marketbeat.comRafferty Asset Management LLC Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP)May 25, 2025 | marketbeat.comJones Trading Initiates Coverage of ArriVent BioPharma (AVBP) with Buy RecommendationMay 21, 2025 | msn.comSuvretta Capital Management LLC Acquires 400,838 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP)May 19, 2025 | marketbeat.comArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key AchievementsMay 17, 2025 | msn.comArriVent BioPharma (NASDAQ:AVBP) Announces Earnings Results, Misses Estimates By $1.24 EPSMay 15, 2025 | marketbeat.comArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Bought by Octagon Capital Advisors LPMay 15, 2025 | marketbeat.comIs ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans?May 14, 2025 | uk.finance.yahoo.comArriVent BioPharma (NASDAQ:AVBP) Trading Down 6.7% - Here's WhyMay 14, 2025 | marketbeat.comArriVent BioPharma: Promising Clinical Developments and Strategic Advancements Justify Buy RatingMay 12, 2025 | tipranks.comArriVent BioPharma Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comArriVent BioPharma (AVBP) to Release Earnings on WednesdayMay 9, 2025 | marketbeat.comBarclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP)May 6, 2025 | marketbeat.comInvesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP)May 6, 2025 | marketbeat.com Get ArriVent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AVBP and its competitors with MarketBeat's FREE daily newsletter. Email Address AVBP Media Mentions By Week AVBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVBP News Sentiment▼0.040.58▲Average Medical News Sentiment AVBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVBP Articles This Week▼63▲AVBP Articles Average Week Get ArriVent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AVBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kymera Therapeutics News Today Metsera News Today Crinetics Pharmaceuticals News Today Viking Therapeutics News Today MoonLake Immunotherapeutics News Today MorphoSys News Today Alvotech News Today HUTCHMED News Today Immunovant News Today Catalyst Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVBP) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts